Literature DB >> 22107839

CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels.

L Skrgatic1, D Pavicic Baldani, J Z Cerne, P Ferk, K Gersak.   

Abstract

Hyperandrogenemia has been the most consistent feature of polycystic ovary syndrome (PCOS). Androgens exert their effects through androgen receptors (ARs). The expansion of the codon CAG trinucleotide repeat polymorphism in exon 1 of the AR gene represents a type of genetic alteration associated with changes in the AR gene function. The purpose of this study was to establish a possible association of the AR gene CAG repeat length polymorphism with PCOS, and its influence on clinical and biochemical androgen traits. Two hundred and fourteen Croatian women with PCOS and 209 healthy control women of reproductive age were enrolled. Phenotypic hyperandrogenism, BMI and waist to hip ratio were recorded. Hormonal profiles, fasting insulin and glucose levels were measured on cycle days 3-5. Genotyping of the CAG repeat polymorphism in the AR gene was performed. We found no significant difference in the mean CAG repeat number between the PCOS patients and controls (22.1±3.4 vs. 21.9±3.2, P=0.286). There was a positive correlation between the CAG repeat length and total testosterone (TT) in the PCOS group (R=0.225, P=0.015). A multiple linear regression model using mean CAG repeat length, BMI, age and HOMA-IR as predictors explained 8.5% (adjusted R²) of the variability in serum TT levels. In this model the CAG repeat polymorphism was found to be a significant predictor of serum TT levels in PCOS patients (P=0.015). The logistic regression analysis revealed that the CAG repeat length is not a significant predictor of hirsutism and acne status (P=0.921 and P=0.437, respectively). The model was adjusted for serum TT, free testosterone, androstendione and DHEAS levels as independent variables, which were also not found to be significant predictors of hirsutism (P=0.687, P=0.194, P=0.675 and P=0.938, respectively) or acne status (P=0.594, P=0.095, P=0.290 and P=0.151, respectively). In conclusion, the AR CAG repeat polymorphism is not a major determinant of PCOS in the Croatian population, but it is a predictor of serum TT level variability in women with PCOS.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22107839     DOI: 10.1016/j.jsbmb.2011.11.006

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  18 in total

1.  The association between androgen receptor gene CAG polymorphism and polycystic ovary syndrome: a case-control study and meta-analysis.

Authors:  Cui Ying Peng; Hui Jun Xie; Zi Fen Guo; Yu Lin Nie; Jun Chen; Jun Mei Zhou; Jie Yin
Journal:  J Assist Reprod Genet       Date:  2014-07-02       Impact factor: 3.412

2.  Androgen receptor (AR) gene CAG trinucleotide repeat length associated with body composition measures in non-syndromic obese, non-obese and Prader-Willi syndrome individuals.

Authors:  Merlin G Butler; Ann M Manzardo
Journal:  J Assist Reprod Genet       Date:  2015-05-01       Impact factor: 3.412

3.  Androgen Receptor Coregulator CTBP1-AS Is Associated With Polycystic Ovary Syndrome in Chinese Women: A Preliminary Study.

Authors:  Zhenteng Liu; Cuifang Hao; Dehua Song; Ning Zhang; Hongchu Bao; Qinglan Qu
Journal:  Reprod Sci       Date:  2014-12-31       Impact factor: 3.060

Review 4.  Negative association between androgen receptor gene CAG repeat polymorphism and polycystic ovary syndrome? A systematic review and meta-analysis.

Authors:  Rui Wang; Mark O Goodarzi; Ting Xiong; Di Wang; Ricardo Azziz; Hanwang Zhang
Journal:  Mol Hum Reprod       Date:  2012-06-12       Impact factor: 4.025

Review 5.  Physiological and Pathological Androgen Actions in the Ovary.

Authors:  Olga Astapova; Briaunna M N Minor; Stephen R Hammes
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

6.  Antiandrogen Treatment Ameliorates Reproductive and Metabolic Phenotypes in the Letrozole-Induced Mouse Model of PCOS.

Authors:  Genevieve E Ryan; Shaddy Malik; Pamela L Mellon
Journal:  Endocrinology       Date:  2018-04-01       Impact factor: 4.736

7.  Androgen receptor CAG repeats length polymorphism and the risk of polycystic ovarian syndrome (PCOS).

Authors:  Singh Rajender; Silas Justin Carlus; Sandeep Kumar Bansal; Mahendra Pal Singh Negi; Mahendra Pratap Singh Negi; Nirmala Sadasivam; Muthusamy Narayanan Sadasivam; Kumarasamy Thangaraj
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

8.  Polycystic ovary syndrome woman with heterozygous androgen receptor gene mutation who gave birth to a child with androgen insensitivity syndrome.

Authors:  Hyoun Nam; Chung-Hoon Kim; Min-Young Cha; Jae-Min Kim; Byung-Moon Kang; Han-Wook Yoo
Journal:  Obstet Gynecol Sci       Date:  2015-03-16

9.  The role of androgen receptor activity mediated by the CAG repeat polymorphism in the pathogenesis of PCOS.

Authors:  N Baculescu
Journal:  J Med Life       Date:  2013-03-25

10.  Relationships among androgen receptor CAG repeat polymorphism, sex hormones and penile length in Han adult men from China: a cross-sectional study.

Authors:  Yan-Min Ma; Kai-Jie Wu; Liang Ning; Jin Zeng; Bo Kou; Hong-Jun Xie; Zhen-Kun Ma; Xin-Yang Wang; Yong-Guang Gong; Da-Lin He
Journal:  Asian J Androl       Date:  2014 May-Jun       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.